Eric Jonasch, Nizar M. Tannir, Andrew Warren Hahn, Sangeeta Goswami, Pavlos Msaouel, Amishi Yogesh Shah, Rebecca Slack Tidwell, Hyunsoo Hwang, Lauren Michelle Wood, Mashaal Syed, Travis Solley, Sara Fares, Lauren S Lewis, Elaine Brooks, Heddy Bartell, Daniel J. George, Naomi Balzer Haas, Michael R. Harrison, Hans J. Hammers, Brian I. Rini. "A randomized phase 2 trial of nivolumab, relatlimab plus ipilimumab vs. nivolumab plus ipilimumab in first-line advanced renal cell carcinoma.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.7_suppl.tps580